Stempoint Capital »

Avidity Biosciences Ord shares owned by Stempoint Capital

Quarter-by-quarter ownership of Avidity Biosciences Ord (RNA) shares owned by Stempoint Capital from 13F filings

Historical chart of Stempoint Capital investment in Avidity Biosciences Ord

Tip: Access up to 7 years of quarterly data

All positions including Avidity Biosciences Ord held by Stempoint Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Avidity Biosciences Ord by Stempoint Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $5.0M 114k 43.57
2024-03-31 $184k 75k 2.45

More positions owned by Stempoint Capital

Abivax Sa Sponsored Ads (ABVX)
Scholar Rock Hldg Corp (SRRK)
Centessa Pharmaceuticals Sponsored Ads (CNTA)
Syndax Pharmaceuticals (SNDX)
Structure Therapeutics Sponsored Ads (GPCR)
Arcellx Common Stock (ACLX)
Roivant Sciences SHS (ROIV)
Terns Pharmaceuticals (TERN)
Twist Bioscience Corp (TWST)
Immunovant (IMVT)
Dyne Therapeutics (DYN)
Xenon Pharmaceuticals (XENE)
Surrozen Com New (SRZN)
Celcuity (CELC)
Mineralys Therapeutics (MLYS)

View all positions for Stempoint Capital

Top funds holding Avidity Biosciences Ord

FMR
Henderson Group
Vanguard Group
BlackRock
Wellington Management Company
RA Capital Management
venBio Select Advisor
State Street Corporation
Goldman Sachs Group
Geode Capital Management
Norges Bank Investment Management
Bellevue Group
Glazer Capital
UBS Group
Susquehanna International

View all funds holding Avidity Biosciences Ord